Literature DB >> 4688703

Nonlinkage of neurovirulence exclusively to viral hemagglutinin or neuraminidase in genetic recombinants of A-NWS (HON1) influenza virus.

V Mayer, J L Schulman, E D Kilbourne.   

Abstract

Genetic recombination of the neurovirulent A/NWS/cc-p (H0N1) and the non-neurovirulent A/Jap.305/57 (H2N2) influenza viruses in which hemagglutinin and neuraminidase were segregated (H0N2, H2N1) were studied for neurovirulence in mice immunosuppressed with cyclophosphamide (CPA) which permitted full expression of virulence. Both H0N2 and H2N1 recombinants replicated in the brain (in contrast to the H2N2 parent) and both produced lethal effects in CPA-treated animals. Therefore we conclude that A/NWS (H0N1) neurovirulence is not exclusively linked with either the hemagglutinin or the neuraminidase of the virus. The H0N2 and H2N1 recombinants have revealed the existence of two separate attributes of neurovirulence: (i) the capacity of virus to initiate intracerebral infection and (ii) the capacity of infection, once initiated, to produce lethal disease. These studies provide further evidence for the polygenic nature of A/NWS neurovirulence.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4688703      PMCID: PMC355092     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  8 in total

1.  GENETIC STUDIES OF INFLUENZA VIRUSES. II. PLAQUE FORMATION BY INFLUENZA VIRUSES IN A CLONE OF A VARIANT HUMAN HETEROPLOID CELL LINE.

Authors:  A SUGIURA; E D KILBOURNE
Journal:  Virology       Date:  1965-07       Impact factor: 3.616

2.  Features of the MEL x NWS recombination systems in influenza A virus. IV. Increments of virulence during successive cycles of double infection with two strains of influenza A virus.

Authors:  K B FRASER
Journal:  Virology       Date:  1959-10       Impact factor: 3.616

3.  The experimental production of combination forms of virus. V. Alterations in the virulence of neurotropic influenza virus as a result of mixed infection.

Authors:  G K HIRST; T GOTLIEB
Journal:  Virology       Date:  1955-07       Impact factor: 3.616

4.  Potentiation of experimental arbovirus encephalitis by immunosuppressive doses of cyclophosphamide.

Authors:  G A Cole; N Nathanson
Journal:  Nature       Date:  1968-10-26       Impact factor: 49.962

5.  The inhibitor-destroying activity of influenza A virus strains of differing neurovirulence for mice.

Authors:  D Hobson; H I Flockton; E A Gould
Journal:  J Gen Virol       Date:  1968-12       Impact factor: 3.891

6.  Genetic studies of influenza viruses. 3. Production of plaque-type recombinants with A0 and A1 strains.

Authors:  A Sugiura; E D Kilbourne
Journal:  Virology       Date:  1966-05       Impact factor: 3.616

7.  Independent variation in nature of hemagglutinin and neuraminidase antigens of influenza virus: distinctiveness of hemagglutinin antigen of Hong Kong-68 virus.

Authors:  J L Schulman; E D Kilbourne
Journal:  Proc Natl Acad Sci U S A       Date:  1969-06       Impact factor: 11.205

8.  Morphological and quantitative comparison between infectious and non-infectious forms of influenza virus.

Authors:  G H WERNER; R W SCHLESINGER
Journal:  J Exp Med       Date:  1954-08-01       Impact factor: 14.307

  8 in total
  14 in total

1.  Effect of immunosuppression on the genetic resistance of A2G mice to neurovirulent influenza virus.

Authors:  R A Fiske; P A Klein
Journal:  Infect Immun       Date:  1975-03       Impact factor: 3.441

Review 2.  Modulation of Host Immunity by the Human Metapneumovirus.

Authors:  Pablo F Céspedes; Christian E Palavecino; Alexis M Kalergis; Susan M Bueno
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

3.  Molecular basis of reovirus virulence: role of the S1 gene.

Authors:  H L Weiner; D Drayna; D R Averill; B N Fields
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

4.  Changes in the hemagglutinin gene of the neurovirulent influenza virus strain A/NWS/33.

Authors:  A C Ward; T F de Koning-Ward
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

5.  Changes in the neuraminidase of neurovirulent influenza virus strains.

Authors:  A C Ward
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

Review 6.  Pathogenicity of influenza virus.

Authors:  C Sweet; H Smith
Journal:  Microbiol Rev       Date:  1980-06

7.  Plaquing characteristics of influenza A virus recombinants of defined genetic composition. Brief report.

Authors:  J S Oxford; K A Callow; T Corcoran; A S Beare
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

8.  Genetically determined resistance to infection by hepatotropic influenza A virus in mice: effect of immunosuppression.

Authors:  O Haller; H Arnheiter; J Lindenmann
Journal:  Infect Immun       Date:  1976-03       Impact factor: 3.441

9.  Murine influenza virus encephalomyelitis. III. Effect of defective interfering virus particles.

Authors:  E T Gamboa; D H Harter; P E Duffy; K C Hsu
Journal:  Acta Neuropathol       Date:  1976-03-15       Impact factor: 17.088

10.  Attenuation of pathogenicity of fowl plague virus by recombination with other influenza A viruses nonpathogenic for fowl: nonexculsive dependence of pathogenicity on hemagglutinin and neuraminidase of the virus.

Authors:  R Rott; M Orlich; C Scholtissek
Journal:  J Virol       Date:  1976-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.